NEPHRAMINE 5.4% Drug Patent Profile
✉ Email this page to a colleague
When do Nephramine 5.4% patents expire, and what generic alternatives are available?
Nephramine 5.4% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in NEPHRAMINE 5.4% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nephramine 5.4%
A generic version of NEPHRAMINE 5.4% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for NEPHRAMINE 5.4%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NEPHRAMINE 5.4% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NEPHRAMINE 5.4%
US Patents and Regulatory Information for NEPHRAMINE 5.4%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | NEPHRAMINE 5.4% | amino acids | INJECTABLE;INJECTION | 017766-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |